Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
This study has been completed.
Study NCT00289536   Information provided by Baxter Healthcare Corporation
First Received: February 9, 2006   Last Updated: July 24, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hemophilia A
More general conditions related to this trial
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Coagulation Protein Disorders
Genetic Diseases, Inborn
Hematologic Diseases
Hemorrhagic Disorders
Additional drug interventions recognized in this trial
Factor VIII
More general drug interventions related to this trial
Coagulants
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Baxter Healthcare Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services